Evoke Pharma
Financial ratios & Valuation

Forward Multiples (2025 – 2026)

20252026
Price/Earnings ratio
57.220.42
Price/Sales ratio
8.525.83
Earnings per Share (EPS)
$0.1$0.28

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-2.68-1.76-1.75-2.75-5.44-5.09-4.96-1.96-1.03-0.45-0.73-5.44
Price/Sales ratio
N/AN/AN/AN/AN/AN/A2.85K10.943.350.672.41N/A
Price/Book Value ratio
3.876.174.9815.5510.238.24-20.464.982.06-1.361.488.24
Price/Cash Flow ratio
-3.09-2.04-2.16-3.86-5.90-6.27-9.92-1.43-1.27-0.70-0.91-5.90
Price/Free Cash Flow ratio
-3.09-2.04-2.16-3.86-5.90-6.27-9.92-1.43-1.27-0.70-0.91-5.90
Price/Earnings Growth ratio
-0.030.110.040.090.120.16-0.070.040.040.04-0.030.16
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/A-276.68%79.72%85.23%96.10%85.23%N/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/A-56678.31%-503.78%-310.37%-143.43%-310.37%N/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/A-57144.53%-527.66%-327.83%-150.41%-327.83%N/A
Net Profit Margin
N/AN/AN/AN/AN/AN/A-57610.74%-558.03%-325.35%-150.41%-327.83%N/A
Effective Tax Rate
N/AN/A-7.45%0.05%12.05%0.40%-0.81%-5.75%0.75%N/AN/A0.40%
Return on Assets
-86.57%-127.16%-115.64%-153.98%-133.68%-110.96%-140.57%-85.39%-68.87%-110.23%-69.39%-133.68%
Return On Equity
-144.17%-349.83%-283.77%-564.67%-187.96%-162.00%412.55%-253.98%-199.82%302.08%-175.51%-187.96%
Return on Capital Employed
-97.91%-153.52%-133.76%-191.42%-199.10%-163.32%-687.29%-88.92%-76.35%-184.26%-76.35%-199.10%
Liquidity Ratios
Current Ratio
8.145.196.573.823.453.091.23N/AN/AN/A7.083.45
Quick Ratio
8.145.196.573.823.453.091.207.386.912.096.323.45
Cash ratio
7.564.736.383.703.252.811.076.505.941.565.943.25
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/A369.6166.5890.9147.4290.91N/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/A995.42206.38285.16871.17285.16N/A
Operating Cycle
N/AN/AN/AN/AN/AN/A1.36K272.97376.07918.59307.58N/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/A5.36K972.27855.663.09K920.70N/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/A-3.99K-699.29-479.59-2.17K-759.48N/A
Debt Ratios
Debt Ratio
0.280.45N/AN/AN/A0.020.540.470.431.410.650.65
Debt Equity Ratio
0.471.26N/AN/AN/A0.03-1.581.401.25-3.871.901.90
Long-term Debt to Capitalization
0.310.54N/AN/AN/AN/A2.800.580.552.06N/AN/A
Total Debt to Capitalization
0.320.55N/AN/AN/A0.032.700.580.551.34N/A0.03
Interest Coverage Ratio
-121.94N/AN/AN/AN/AN/A-115.46N/AN/AN/A-15.57N/A
Cash Flow to Debt Ratio
-2.61-2.39N/AN/AN/A-41.59-1.29-2.46-1.28-0.49N/AN/A
Company Equity Multiplier
1.662.752.453.661.401.46-2.932.972.90-2.742.901.40
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/A-288.01-7.63-2.62-0.96-2.63N/A
Free Cash Flow / Operating Cash Flow Ratio
111111111111
Cash Flow Coverage Ratio
-2.61-2.39N/AN/AN/A-41.59-1.29-2.46-1.28-0.49N/AN/A
Short Term Coverage Ratio
-76.45-71.86N/AN/AN/A-41.59-63.64-993.96-51.10-0.99-51.12-41.59
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A